In questo Ottobre... - Istituti Clinici Scientifici Maugeri | Facebook
Antonio Bernardo | ICS Maugeri
I 20 oncologi più suggeriti a Pavia - MioDottore.it
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge
News | Page 4 | ICS Maugeri
Untitled
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients? - Raffaella Palumbo, Federico Sottotetti, Antonio Bernardo, 2016
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force☆ - ESMO Open
In questo Ottobre... - Istituti Clinici Scientifici Maugeri | Facebook
17_PPR07 PROGRAMMA BOZZA 27_02
In questo Ottobre... - Istituti Clinici Scientifici Maugeri | Facebook
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience - Falanga - 2022 - Thoracic Cancer - Wiley Online Library
In questo Ottobre... - Istituti Clinici Scientifici Maugeri | Facebook
Federico Sottotetti | ICS Maugeri
Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places
17_PPR07 PROGRAMMA BOZZA 27_02
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study - Vincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, Dario Giuffrida, Giuseppa Scandurra, Antonio Russo, Livio
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for
Oncologia | ICS Maugeri
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer
REAL WORLD OUTCOMES IN MBC
Covid: le paure di medici e infermieri - la Repubblica
